From the ECB's perspective, they're in a real sweet spot. They've cut rates down to 2.15% from a high of 4.50%, which has put some stimulus in the pipeline but has also left them with some dry powder if they need to cut further.
From the ECB's perspective, they're in a real sweet spot. They've cut rates down to 2.15% from a high of 4.50%, which has put some stimulus in the pipeline but has also left them with some dry powder if they need to cut further.
Most Popular
HCI Group soars 5.1% on 52.1% revenue growth, beating EPS & book value estimates. SIGI down 3.8% despite solid ROE.
Biotech stocks surge on FDA vaccine chief's exit; UniQure jumps 55%, Regenxbio up 16%.
Inspire Medical (INSP) up 12.2% revenue, but stock down 8.4%. Globus Medical (GMED) beats estimates, stock down 2.8%. STAAR Surgical (STAA) misses, stock down 1.8%.
CAVA surges 17.5% on strong earnings beat; SHAK up 4.9% despite mixed results. SG down 7.2% on weak revenue.
Robinhood's private markets fund tanks 11% on IPO day. Retail investors now face private valuation risks.
Engineering firms beat Q4 revenue estimates by 7.7%, but stocks fell 7.3% on average. AECOM down 8.5%.
Savers chase 5% yields in low-risk accounts like savings, CDs, and Treasuries, avoiding market swings.
Must Read